rsx: A high-performance streaming toolkit for RAD-seq sex determination

Rohit Goswami; Ruhila Goswami

Home/Archive/arXiv

arXiv · 2606.06434

rsx: A high-performance streaming toolkit for RAD-seq sex determination

Rohit Goswami·Ruhila Goswami

View original source ↗Read source document ↗Export metadata ↓

Abstract

Background Restriction site-associated DNA sequencing (RAD-seq) is widely used to discover sex-linked markers in non-model organisms, and RADSex provides the reference workflow for building marker-by-individual depth tables and testing sex-biased marker distributions. Its table-building commands grow memory-hungry as panels reach millions of RAD tags, it reports frequentist calls with no posterior evidence, and it offers no Python or C interface. Results rsx is a Rust implementation of the complete RADSex command set that preserves marker-table semantics and command-line compatibility. It combines 2-bit DNA keys, parallel ingestion, memory-mapped tables, external sorting, bitset group counts and a streamed Gram matrix so that writable allocations stay bounded by the number of individuals or by an explicit buffer, with false-discovery-rate ranking the one deliberate exception. Conjugate Beta-Binomial Bayes factors and directional posteriors grade each marker as a strict call, a posterior-supported hypothesis or a Bayes-factor-only row, and an optional CUDA backend batches the per-marker arithmetic on the GPU. On four published RAD-seq panels comprising 41.9 billion sequenced bases, rsx reproduced the RADSex v1.2.0 calls, recovered every Bonferroni-significant positive-control marker, and was 8.38-fold faster in geometric mean across 56 paired timings; the CUDA backend adds up to 29.86-fold on the p-value batch. Python and C bindings drive the same core from notebooks and pipelines. Conclusions rsx is an allocation-bounded, statistically extended replacement for RADSex that stays backward-compatible and reports its evidence in explicit grades. It is released under the GPL-3.0-or-later licence, with a reproducibility archive covering every reported number.

Explore related subjects

q-bio.GN cs.PF

Keep this discovery

Explore connections, maps & timelines

BibTeX RIS

Rohit Goswami, Ruhila Goswami. 2026-08-03. rsx: A high-performance streaming toolkit for RAD-seq sex determination. https://arxiv.org/abs/2606.06434

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related papers

arXiv2026

Transcriptomic Models for Immunotherapy Response Prediction Show Limited Cross-cohort Generalisability

Immune checkpoint inhibitors (ICIs) have transformed cancer therapy; yet substantial proportion of patients exhibit intrinsic or acquired resistance, making accurate pre-treatment response prediction a critical unmet need. Transcriptomics-based biomarkers derived from bulk and single-cell RNA sequencing (scRNA-seq) offer a promising avenue for capturing tumour-immune interactions, yet the cross-cohort generalisability of existing prediction models remains unclear.We systematically benchmark nine state-of-the-art transcriptomic ICI response predictors, five bulk RNA-seq-based models (COMPASS, IRNet, NetBio, IKCScore, and TNBC-ICI) and four scRNA-seq-based models (PRECISE, DeepGeneX, Tres and scCURE), using publicly available independent datasets unseen during model development. Overall, predictive performance was modest: bulk RNA-seq models performed at or near chance level across most cohorts, while scRNA-seq models showed only marginal improvements. Pathway-level analyses revealed sparse and inconsistent biomarker signals across models. Although scRNA-seq-based predictors converged on immune-related programs such as allograft rejection, bulk RNA-seq-based models exhibited little reproducible overlap. PRECISE and NetBio identified the most coherent immune-related themes, whereas IRNet predominantly captured metabolic pathways weakly aligned with ICI biology. Together, these findings demonstrate the limited cross-cohort robustness and biological consistency of current transcriptomic ICI prediction models, underscoring the need for improved domain adaptation, standardised preprocessing, and biologically grounded model design.

q-bio.GN↗

arXiv2026

Large Language Model Agents for Evidence Based Genetic Disease Severity Classification

Disease severity classification for genetic conditions is subjective and labor-intensive, creating bottlenecks in genomic screening, where commercial panels vary widely in size and overlap. We developed an autonomous AI agent integrating Reasoning and Acting (ReAct) with Retrieval-Augmented Generation (RAG) to classify 10,211 Human Phenotype Ontology terms. It uses American College of Medical Genetics (ACMG)-endorsed severity guidelines and American College of Obstetricians and Gynecologists (ACOG) quality-of-life criteria to retrieve PubMed literature, generate interpretable reasoning chains, and independently verify claims. At the phenotype level, using expert-curated cohorts, the agent achieved 93.55% accuracy (MCC 0.9237) with 82.6% to 91.4% of claims supported by direct evidence or valid inferences. Gene-level severity was aggregated across 8,738 pairs, identifying 3,283 autosomal recessive pairs with severe or profound presentations. External validation showed 95.2% concordance with Mackenzie's Mission gene list. This system enables standardized panel design by providing reliable, automated classification supported by direct evidence.

q-bio.GN↗

arXiv2026

Harmonised benchmarking of foundation models for single-cell and spatial transcriptomics reveals context-dependent generalisation

Single-cell and spatial foundation models promise transferable biological representations, yet their generality remains largely untested across modalities, biological domains and analytical tasks. We benchmarked six representative models, Nicheformer, CellPLM, scGPT-spatial, GenePT, scELMo and Novae, using a harmonised framework spanning scRNA-seq, spatial transcriptomics and Perturb-seq. We evaluated zero-shot and continually pretrained clustering, supervised annotation, marker-gene concordance and perturbation prediction. Model performance was strongly conditional: expression-trained cell-level transformers best resolved many cell-identity tasks, spatial and graph-aware models better preserved tissue architecture, and language-derived gene embeddings were competitive for selected perturbation-response metrics. No model dominated across tasks, and rankings shifted with modality, preprocessing, tokenisation, biological prior, domain shift and metric choice. This benchmark provides practical guidance for model selection and argues that future models should be judged by biological generalisation, interpretability and perturbation-grounded validity, not by scale or leaderboard performance alone.

q-bio.GN↗